Ann: Application for quotation of securities - ILA, page-30

I think I'm right in saying that there's no known vaccine for dengue fever. (Which is both the problem and the opportunity.)

But the FA that people are always overlooking with ILA ...

https://hotcopper.com.au/threads/ann-grant-funding-to-directly-support-phase-2a-trial.7991190/

AUD960k for ILA (there was a further AUD1m awarded to the The
Research Foundation for the State University of New York (SUNY) ... maybe more will trickle through to ILA in due course.)

(By the way ... I assume ILA also get the tax rebate on this expenditure.)

and in 2023

https://hotcopper.com.au/threads/ann-us-grant-funding-to-support-isla-101-clinical-development.7468102/

The US$1.3m Congressionally Directed Medical Research Programs (CDMRP) grant will
support laboratory testing and data analysis during Island’s planned clinical trial at SUNY
in Syracuse. The trial will evaluate the effectiveness of Island’s ISLA-101 drug candidate to
treat dengue fever induced in the human challenge model. The funding will enable Island
to signficiantly expand on the data being generated during the trial, further characterizing
Island’s intellectual property (IP). These studies are anticipated to increase the
understanding of dengue infections and may also identify biomarkers of infection that
could further aid in the development of effective therapies and diagnostics.

REAL MONEY SUPPORT FROM THE US (Dept of Defence) So that makes USD2.6m towards supporting ILA/dengue solution, of which AUD960k is going directly to ILA to help fund the trials.

Show me another AUD8m company (on the ASX) with such US Govt support and such huge potential.

A diamond in the rough?